12 Health Care Stocks Moving In Thursday's Intraday Session
GainersAclarion (NASDAQ:ACON) shares moved upwards by 66.7% to $0.48 during Thursday's regular session. The market value of their outstanding shares is at $3.4 million. Processa Pharma (NASDAQ:PCSA) s
Express News | Eyenovia Shares Are Trading Higher After the Company Announced Clinical and Scientific Updates on Its FDA-approved Products Mydcombi and Clobetasol Propionate Ophthalmic Suspension
Express News | Eyenovia Provides Clinical and Scientific Update On FDA-Approved Products Mydcombi And Clobetasol Propionate Ophthalmic Suspension
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersAdial Pharmaceuticals (NASDAQ:ADIL) shares rose 61.6% to $1.83 during Wednesday's regular session. The company's market cap stands at $7.4 million. Jaguar Health (NASDAQ:JAGX) shares rose 32.22
Eyenovia Shares Fall More Than 14% After Company Says It Is Exploring Sale
By Emon Reiser Shares of Eyenovia were on the decline after the commercial-stage ophthalmic company said it was exploring strategic options, including a potential sale. The stock decreased 14.6% to
Eyenovia Explores Options, Including Potential Sale
By Colin Kellaher Eyenovia on Monday said it is exploring strategic options, including a potential sale of the ophthalmic company. In addition to a sale, Eyenovia, said it plans to consider a range
Eyenovia Initiates Process To Explore Strategic Alternatives To Maximize Shareholder Value
The company announced its plans for accelerating development of its potential multi-billion dollar product for pediatric progressive myopia (MicroPine). In conjunction with the strategic process and f
Eyenovia(EYEN.US) 10% Shareholder Buys US$98,000 in Common Stock
$Eyenovia(EYEN.US)$ 10% Shareholder Grant Stuart M. purchased 100K shares of Common Stock on Mar 28, 2024 at an average price of $0.98 for a total value of $98,000.Source: Announcement What is stateme
Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones index closed higher by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders
Eyenovia(EYEN.US) 10% Shareholder Buys US$61,500 in Common Stocks
$Eyenovia(EYEN.US)$ 10% Shareholder Grant Stuart M. purchased 50,000 shares of Common Stocks on Mar 19, 2024 at an average price of $1.23 for a total value of $61,500.Source: Announcement What is stat
Eyenovia's Financial Future in Jeopardy: Reliance on Two FDA-Approved Products Raises Profitability Concerns
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersOntrak (NASDAQ:OTRK) shares increased by 97.6% to $0.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.3 million. Fusion Pharmaceuticals (NASDAQ:FUSN)
OTRK, STRC and APM Among Mid-day Movers
Express News | Eyenovia Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results
Graphite Bio, SCWorx, Acurx Pharmaceuticals Among Healthcare Movers
Eyenovia Inc Presents Updated Corporate Strategy Overview
Eyenovia's Strategic Commercial Synergy and Growth Potential Reinforce Buy Rating
Earnings Call Summary | Eyenovia(EYEN.US) Q4 2023 Earnings Conference
The following is a summary of the Eyenovia, Inc. (EYEN) Q4 2023 Earnings Call Transcript:Financial Performance:Insufficient financial data to provide a summary.Business Progress:Insufficient business
Eyenovia, Inc. (EYEN) Reports Q4 Loss, Misses Revenue Estimates
Recap: Eyenovia Q4 Earnings
Eyenovia (NASDAQ:EYEN) reported its Q4 earnings results on Monday, March 18, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsEyenovia missed estimated earnings by -6
No Data